Emisjoner, børsnoteringer m.m.

Recipharm AB

(19.05.2016) DNB Markets is acting as Joint Bookrunner in relation to the rights issue in Recipharm AB (publ) (“Recipharm” or the “Company”) on Nasdaq Stockholm.